日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry

CDK 4/6抑制剂的应用及其对HR+/HER2-晚期乳腺癌患者治疗选择的影响：一项来自荷兰SONABRE注册研究

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.33785
Meegdes, Marissa; Geurts, Sandra M E; Erdkamp, Frans L G; Dercksen, Marcus Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Teeuwen, Nathalie J A; de Boer, Maaike; Tjan-Heijnen, Vivianne C G
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches

组织学亚型在激素受体阳性转移性乳腺癌中的作用：生存期相似但治疗方法不同

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.8838
Lobbezoo, Dorien; Truin, Wilfred; Voogd, Adri; Roumen, Rudi; Vreugdenhil, Gerard; Dercksen, Marcus Wouter; van den Berkmortel, Franchette; Smilde, Tineke; van de Wouw, Agnes; van Kampen, Roel; van Riel, Johanna; Peters, Natascha; Peer, Petronella; Tjan-Heijnen, Vivianne C G
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2016
文献求助 收藏